vs

Side-by-side financial comparison of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and SmartStop Self Storage REIT, Inc. (SMA). Click either name above to swap in a different company.

IOVANCE BIOTHERAPEUTICS, INC. is the larger business by last-quarter revenue ($86.8M vs $78.4M, roughly 1.1× SmartStop Self Storage REIT, Inc.). On growth, SmartStop Self Storage REIT, Inc. posted the faster year-over-year revenue change (29.4% vs 17.7%). Over the past eight quarters, IOVANCE BIOTHERAPEUTICS, INC.'s revenue compounded faster (1001.6% CAGR vs 17.3%).

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

SmartStop Self Storage REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality self-storage properties. Its portfolio covers multiple U.S. states and Canadian provinces, offering secure, flexible storage solutions for residential customers storing personal belongings and commercial clients storing inventory or seasonal goods.

IOVA vs SMA — Head-to-Head

Bigger by revenue
IOVA
IOVA
1.1× larger
IOVA
$86.8M
$78.4M
SMA
Growing faster (revenue YoY)
SMA
SMA
+11.6% gap
SMA
29.4%
17.7%
IOVA
Faster 2-yr revenue CAGR
IOVA
IOVA
Annualised
IOVA
1001.6%
17.3%
SMA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IOVA
IOVA
SMA
SMA
Revenue
$86.8M
$78.4M
Net Profit
$3.0M
Gross Margin
67.4%
61.2%
Operating Margin
-84.7%
24.0%
Net Margin
3.8%
Revenue YoY
17.7%
29.4%
Net Profit YoY
2080.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IOVA
IOVA
SMA
SMA
Q4 25
$86.8M
$78.4M
Q3 25
$67.5M
$70.4M
Q2 25
$60.0M
$66.8M
Q1 25
$49.3M
$65.4M
Q4 24
$73.7M
$60.6M
Q3 24
$58.6M
$60.2M
Q2 24
$31.1M
$59.2M
Q1 24
$715.0K
$57.0M
Net Profit
IOVA
IOVA
SMA
SMA
Q4 25
$3.0M
Q3 25
$-91.3M
$5.2M
Q2 25
$-111.7M
$-4.8M
Q1 25
$-116.2M
$-5.5M
Q4 24
$-150.0K
Q3 24
$-83.5M
$-6.2M
Q2 24
$-97.1M
$-705.0K
Q1 24
$-113.0M
$-1.6M
Gross Margin
IOVA
IOVA
SMA
SMA
Q4 25
67.4%
61.2%
Q3 25
43.0%
60.9%
Q2 25
5.5%
59.3%
Q1 25
-0.8%
64.1%
Q4 24
68.7%
66.3%
Q3 24
46.2%
64.8%
Q2 24
-0.8%
66.4%
Q1 24
65.1%
Operating Margin
IOVA
IOVA
SMA
SMA
Q4 25
-84.7%
24.0%
Q3 25
-140.7%
18.1%
Q2 25
-189.8%
15.4%
Q1 25
-245.8%
26.3%
Q4 24
-117.5%
29.4%
Q3 24
-152.1%
29.4%
Q2 24
-327.6%
29.9%
Q1 24
-16464.6%
28.0%
Net Margin
IOVA
IOVA
SMA
SMA
Q4 25
3.8%
Q3 25
-135.3%
7.4%
Q2 25
-186.2%
-7.2%
Q1 25
-235.5%
-8.3%
Q4 24
-0.2%
Q3 24
-142.7%
-10.3%
Q2 24
-312.2%
-1.2%
Q1 24
-15800.8%
-2.9%
EPS (diluted)
IOVA
IOVA
SMA
SMA
Q4 25
Q3 25
$0.09
Q2 25
$-0.33
$-0.16
Q1 25
$-0.36
$-0.35
Q4 24
$-0.24
Q3 24
$-0.28
$-0.26
Q2 24
$-0.34
$-0.16
Q1 24
$-0.42
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IOVA
IOVA
SMA
SMA
Cash + ST InvestmentsLiquidity on hand
$297.0M
$54.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$698.6M
$1.2B
Total Assets
$913.2M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IOVA
IOVA
SMA
SMA
Q4 25
$297.0M
$54.2M
Q3 25
$300.8M
$47.8M
Q2 25
$301.2M
$37.7M
Q1 25
$359.7M
$35.2M
Q4 24
$323.8M
$23.1M
Q3 24
$397.5M
$36.7M
Q2 24
$412.5M
$34.7M
Q1 24
$356.2M
$39.2M
Stockholders' Equity
IOVA
IOVA
SMA
SMA
Q4 25
$698.6M
$1.2B
Q3 25
$702.3M
$1.2B
Q2 25
$698.5M
$1.2B
Q1 25
$767.9M
$303.0M
Q4 24
$710.4M
$325.7M
Q3 24
$773.5M
$343.9M
Q2 24
$768.5M
$365.8M
Q1 24
$680.0M
$384.8M
Total Assets
IOVA
IOVA
SMA
SMA
Q4 25
$913.2M
$2.4B
Q3 25
$904.9M
$2.4B
Q2 25
$907.4M
$2.3B
Q1 25
$966.7M
$2.1B
Q4 24
$910.4M
$2.0B
Q3 24
$991.1M
$1.9B
Q2 24
$964.3M
$1.9B
Q1 24
$869.8M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IOVA
IOVA
SMA
SMA
Operating Cash FlowLast quarter
$-52.6M
$85.0M
Free Cash FlowOCF − Capex
$-61.9M
FCF MarginFCF / Revenue
-71.3%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
28.61×
TTM Free Cash FlowTrailing 4 quarters
$-336.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IOVA
IOVA
SMA
SMA
Q4 25
$-52.6M
$85.0M
Q3 25
$-78.7M
$52.1M
Q2 25
$-67.4M
$8.0M
Q1 25
$-103.7M
$10.6M
Q4 24
$-73.3M
$64.0M
Q3 24
$-59.0M
$21.7M
Q2 24
$-98.4M
$17.3M
Q1 24
$-122.3M
$14.4M
Free Cash Flow
IOVA
IOVA
SMA
SMA
Q4 25
$-61.9M
Q3 25
$-89.5M
Q2 25
$-74.9M
Q1 25
$-109.9M
Q4 24
$-77.5M
Q3 24
$-61.3M
Q2 24
$-98.9M
Q1 24
$-126.5M
FCF Margin
IOVA
IOVA
SMA
SMA
Q4 25
-71.3%
Q3 25
-132.7%
Q2 25
-124.9%
Q1 25
-222.8%
Q4 24
-105.1%
Q3 24
-104.6%
Q2 24
-317.9%
Q1 24
-17685.3%
Capex Intensity
IOVA
IOVA
SMA
SMA
Q4 25
10.7%
Q3 25
16.1%
Q2 25
12.4%
Q1 25
12.6%
Q4 24
5.7%
Q3 24
3.9%
Q2 24
1.4%
Q1 24
583.4%
Cash Conversion
IOVA
IOVA
SMA
SMA
Q4 25
28.61×
Q3 25
9.96×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IOVA
IOVA

Amtagvi$64.9M75%
Proleukin$21.9M25%

SMA
SMA

Self Storage Rental Revenue$62.0M79%
Other$11.9M15%
Ancillary Operating Revenue$2.9M4%
Asset Management1$1.7M2%

Related Comparisons